agilon health (AGL) Competitors $1.97 +0.09 (+4.79%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends AGL vs. VCYT, BTSG, LFST, SGRY, CON, PRVA, ARDT, ADUS, PACS, and WGSShould you be buying agilon health stock or one of its competitors? The main competitors of agilon health include Veracyte (VCYT), BrightSpring Health Services (BTSG), LifeStance Health Group (LFST), Surgery Partners (SGRY), Concentra Group Holdings Parent (CON), Privia Health Group (PRVA), Ardent Health Partners (ARDT), Addus HomeCare (ADUS), PACS Group (PACS), and GeneDx (WGS). These companies are all part of the "healthcare" industry. agilon health vs. Veracyte BrightSpring Health Services LifeStance Health Group Surgery Partners Concentra Group Holdings Parent Privia Health Group Ardent Health Partners Addus HomeCare PACS Group GeneDx agilon health (NYSE:AGL) and Veracyte (NASDAQ:VCYT) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, valuation, dividends, media sentiment, institutional ownership, profitability, community ranking, earnings and risk. Which has more risk & volatility, AGL or VCYT? agilon health has a beta of 0.51, suggesting that its share price is 49% less volatile than the S&P 500. Comparatively, Veracyte has a beta of 1.69, suggesting that its share price is 69% more volatile than the S&P 500. Which has higher valuation and earnings, AGL or VCYT? Veracyte has lower revenue, but higher earnings than agilon health. Veracyte is trading at a lower price-to-earnings ratio than agilon health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratioagilon health$5.59B0.15-$262.60M-$0.94-2.10Veracyte$425.33M7.45-$74.40M-$0.15-272.60 Does the media favor AGL or VCYT? In the previous week, agilon health had 4 more articles in the media than Veracyte. MarketBeat recorded 8 mentions for agilon health and 4 mentions for Veracyte. Veracyte's average media sentiment score of 0.90 beat agilon health's score of 0.57 indicating that Veracyte is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment agilon health 1 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Veracyte 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community favor AGL or VCYT? Veracyte received 389 more outperform votes than agilon health when rated by MarketBeat users. Likewise, 73.01% of users gave Veracyte an outperform vote while only 46.43% of users gave agilon health an outperform vote. CompanyUnderperformOutperformagilon healthOutperform Votes5246.43% Underperform Votes6053.57% VeracyteOutperform Votes44173.01% Underperform Votes16326.99% Is AGL or VCYT more profitable? Veracyte has a net margin of -2.18% compared to agilon health's net margin of -6.88%. Veracyte's return on equity of 3.02% beat agilon health's return on equity.Company Net Margins Return on Equity Return on Assets agilon health-6.88% -47.84% -14.97% Veracyte -2.18%3.02%2.80% Do analysts rate AGL or VCYT? agilon health currently has a consensus target price of $4.28, indicating a potential upside of 117.43%. Veracyte has a consensus target price of $41.13, indicating a potential upside of 0.57%. Given agilon health's higher possible upside, analysts plainly believe agilon health is more favorable than Veracyte.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score agilon health 3 Sell rating(s) 16 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 1.95Veracyte 1 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.67 SummaryVeracyte beats agilon health on 12 of the 16 factors compared between the two stocks. Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Get agilon health News Delivered to You Automatically Sign up to receive the latest news and ratings for AGL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AGL vs. The Competition Export to ExcelMetricagilon healthhealth & allied services, not elsewhere classified IndustryMedical SectorNYSE ExchangeMarket Cap$811.68M$1.91B$5.14B$19.19BDividend YieldN/A7.04%5.09%3.61%P/E Ratio-2.1015.5789.8241.30Price / Sales0.153.171,116.2117.58Price / CashN/A9.7742.8921.28Price / Book1.213.044.785.32Net Income-$262.60M$69.56M$120.23M$989.88M7 Day Performance-12.05%-1.73%-1.92%-3.54%1 Month Performance10.67%-2.76%11.49%-3.68%1 Year Performance-84.37%-25.02%30.57%12.14% agilon health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AGLagilon health2.3096 of 5 stars$1.97+4.8%$4.28+117.4%-84.0%$811.68M$5.59B-2.101,117Gap DownVCYTVeracyte4.0331 of 5 stars$43.27+0.1%$41.13-5.0%+49.0%$3.35B$361.05M-288.13790Positive NewsBTSGBrightSpring Health Services2.312 of 5 stars$18.94+2.0%$18.50-2.3%N/A$3.30B$10.59B-71.3835,000Analyst ForecastLFSTLifeStance Health Group1.6908 of 5 stars$7.75+8.1%$8.70+12.3%-0.3%$2.97B$1.21B-29.509,325Positive NewsGap UpSGRYSurgery Partners3.2423 of 5 stars$22.17+8.9%$36.56+64.9%-33.8%$2.82B$2.74B-42.4213,500CONConcentra Group Holdings ParentN/A$21.54+5.1%$28.50+32.3%N/A$2.74B$1.88B0.0011,000Gap UpPRVAPrivia Health Group2.8961 of 5 stars$21.42+2.2%$24.80+15.8%-12.6%$2.57B$1.66B209.621,102ARDTArdent Health PartnersN/A$16.89+1.2%$21.82+29.2%N/A$2.41B$5.41B0.0024,200Analyst ForecastPositive NewsADUSAddus HomeCare4.7468 of 5 stars$131.27+5.0%$133.67+1.8%+38.8%$2.38B$1.06B28.6034,846Analyst RevisionPositive NewsPACSPACS Group3.6498 of 5 stars$15.17-1.6%$39.88+162.9%N/A$2.31B$3.11B0.0032,433Analyst ForecastWGSGeneDx1.2637 of 5 stars$77.99+3.4%$59.33-23.9%+2,935.3%$2.14B$267.23M-24.251,200Insider Trade Related Companies and Tools Related Companies Veracyte Alternatives BrightSpring Health Services Alternatives LifeStance Health Group Alternatives Surgery Partners Alternatives Concentra Group Holdings Parent Alternatives Privia Health Group Alternatives Ardent Health Partners Alternatives Addus HomeCare Alternatives PACS Group Alternatives GeneDx Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:AGL) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding agilon health, inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share agilon health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
